"Designing Growth Strategies is in our DNA"

Biopsy Punch Market Size, Share and Industry Analysis, By Product Type (Reusable and Disposable), By Indication (Skin Cancer, Actinic Keratosis, Inflammatory Lesions, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Regional Forecast, 2025-2032

Region :Global | Report ID: FBI110771 | Status : Ongoing

 

KEY MARKET INSIGHTS

The biopsy punch market is witnessing significant growth due to several key factors, such as technological advancements in the development of biopsy tools with enhanced precision and accuracy. Furthermore, there is an increased demand for biopsy procedures due to skin cancer and other dermatological conditions. In addition, the advantages of the method, such as quick and minimally invasive procedures with shorter healing time and a focus on early detection and treatment of skin conditions, are also driving the adoption of such products, which is projected to boost the market growth.



  • For instance, according to the article published by Clinikally in April 2023, punch biopsies are minimally invasive and offer several advantages over other biopsy methods. They can provide a full-thickness sample of skin, which is crucial for accurate diagnosis.


Biopsy Punch Market Driver


Rising Incidence of Skin Cancer Boosts Biopsy Punch Market Growth

In recent years, there has been a significant rise in the incidence of skin cancer worldwide. This is driving the urgent need for accurate diagnostic tools, highlighting the critical role of punch biopsies in the early detection of cancers and treatment planning. This procedure allows for the removal of full-thickness skin samples, providing essential information for diagnosing various skin cancers, including melanoma, which is vital for improving patient outcomes. Such a scenario is anticipated to boost the market growth over the coming years.


  • For instance, as of July 2024, the World Cancer Research Fund International stated that skin cancer is the 17th most common cancer globally, and there were more than 331,722 new cases of skin cancer diagnosed in 2022.


Request a Free sample to learn more about this report.


The U.S. accounted for the highest number of estimated skin cancer cases in 2023, followed by Germany and the U.K.

Biopsy Punch Market Restraint


Preference for Alternative Biopsy Types May Hinder the Market Growth

In several cases, other biopsy techniques, such as excisional biopsies or deep shave biopsies, are preferred for suspected melanomas due to their ability to provide more comprehensive tissue samples. In addition, deep shave biopsy offers more frequent diagnostic capability than punch biopsy. This preference can limit the application of punch biopsies in clinical practice, particularly for high-risk lesions. Such a scenario is expected to hinder the market expansion during the forecast period.


  • For instance, according to a study by the National Center for Biotechnology Information (NCBI) in June 2023, shave biopsy was the most frequent procedure for the diagnosis of cutaneous melanoma in the modern era.


Biopsy Punch Market Opportunity


Emerging Markets to Present Significant Opportunity

The expanding healthcare infrastructure in emerging countries represents a significant opportunity for biopsy punch market growth. The significant rise in healthcare infrastructure boosts access to advanced medical devices, propelling the product demand in these markets. Such a scenario is projected to boost the market growth over the forthcoming years.


  • For instance, according to an article published by the World Economic Forum in June 2024, the healthcare sector in China has benefitted due to vastly improved infrastructure and rapid technological advancements in recent years, driving the demand for medical devices, including biopsy punches.


Key Insights


The report covers the following key insights:


  • Prevalence of Key Diseases, By Key Countries, 2023

  • Key Industry Developments (Mergers, Acquisitions & Partnerships)

  • Technological Advancements in the Biopsy Punch Market

  • Impact of COVID-19 on the Market


Segmentation


















By Product Type


By Indication


By End-user


By Geography



  • Reusable

  • Disposable




  • Skin Cancer

  • Actinic Keratosis

  • Inflammatory Lesions

  • Others




  • Hospitals & Clinics

  • Diagnostic Laboratories

  • Others




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Analysis by Product Type


Based on product type, the market is segmented into reusable and disposable.

The disposable segment is expected to hold a major share of the global market. The preference for disposable biopsy punches is largely driven by their convenience, sterility, cost-effectiveness, and consistent performance, making them the more commonly used option in various applications. In contrast, reusable punches are environmentally friendly and potentially less costly over time. However,  they require rigorous cleaning and sterilization processes, which can be time-consuming. This is driving the demand for disposable punches, which is expected to boost the segment growth during the forecast period.


  • For instance, as of July 2024, an article by World Precision Instruments stated that disposable biopsy punches are often preferred over reusable biopsy punches due to their less expensive, convenient, reliable, and time-saving benefits.


Analysis by Indication


By indication, the market is divided into skin cancer, inflammatory lesions, actinic keratosis, and others.

The skin cancer segment accounts for the largest share of the biopsy punch market. The solutions are currently being used in the diagnosis of skin cancers such as melanoma due to their significant burden across the globe. In consideration of this, the prominent players are offering products for the diagnosis of such diseases, which is expected to propel the segment growth.


  • For instance, as of July 2024, Robbins Instruments’ True-Cut disposable biopsy punch is used to diagnose skin cancer or severe skin infections.


Analysis by End-user


By end-user, the market is segmented into hospitals & clinics, diagnostic laboratories, and others.

The hospital & clinics accounted for a major share of the biopsy punch market in 2023. The growth can be attributed to the increasing number of patients visiting hospitals and dermatology clinics for the diagnosis of skin cancer and related conditions. In addition, the higher rate of skin cancer globally is surging these patient visits to hospitals and clinics due to increased demand for early disease detection, thereby driving the utilization of biopsy punches.


  • For instance, as of July 2024, the American Academy of Dermatology Association states that melanoma rates in the U.S. have been rising rapidly over the last three decades.


Regional Analysis


To gain extensive insights into the market, Request for Customization


Based on region, the market has been studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the global market in 2023. The regional market growth is attributed to the high burden of skin cancer, which is propelling the demand for diagnosis through biopsy punch. Moreover, the high penetration rate of such tools in the region is also expected to contribute to market growth.


  • For instance, in June 2024, the American Academy of Dermatology Association reported that an estimated 9,500 individuals in the U.S. are diagnosed with skin cancer every day. Such a high diagnosis rate is expected to propel the demand for biopsy punch.


Europe is the second-largest market based on the product demand. The regional growth can be attributed to the significant presence of prominent players, ensuring the product availability in consideration of the diagnostic rate of skin cancer and related conditions.

Asia Pacific is expected to grow steadily over the forthcoming years. The regional growth can be attributed to the growing awareness regarding dermatological disorders such as actinic keratosis and skin cancer. This is leading to an increase in the demand for early disease detection, boosting the product adoption in the region.

Key Players Covered


The global market is fragmented, with a large number of companies offering various types of services and products for biopsy punch.

The report includes the profiles of the following key players:


  • SAMSON SURGICALS (India)

  • INNOVIA MEDICAL (U.K.)

  • CooperSurgical Inc. (U.S.)

  • INTEGRA LIFESCIENCES (U.S.)

  • Bako Diagnostics (Georgia)

  • MedGyn Products, Inc. (U.S.)

  • KAI CORPORATION (Japan)

  • Acuderm, Inc. (U.S.)

  • World Precision Instruments (U.S.)


Key Industry Developments



  • In April 2024, Paula Fox Melanoma and Cancer Centre was opened at Alfred in Australia, which is expected to surge the demand for biopsy punches in the number of research studies and trials.

  • In February 2023, INNOVIA MEDICAL launched the oral rotating biopsy punch at BACO International 2023. This launch included two variants of the product: the Oral Rotating Biopsy Punch 120 mm and the Oral Rotating Biopsy Punch Long 180 mm.





  • Ongoing
  • 2024
  • 2019-2023
Consulting Services
    How will you benefit from our consulting services ?
Healthcare Clients
Fresenius
Nihon Kohden
Sanofi
Johnson
National Institutes of Health (NIH)